155 related articles for article (PubMed ID: 2830989)
1. v-jun encodes a nuclear protein with enhancer binding properties of AP-1.
Bos TJ; Bohmann D; Tsuchie H; Tjian R; Vogt PK
Cell; 1988 Mar; 52(5):705-12. PubMed ID: 2830989
[TBL] [Abstract][Full Text] [Related]
2. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.
Bohmann D; Bos TJ; Admon A; Nishimura T; Vogt PK; Tjian R
Science; 1987 Dec; 238(4832):1386-92. PubMed ID: 2825349
[TBL] [Abstract][Full Text] [Related]
3. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
4. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.
Angel P; Allegretto EA; Okino ST; Hattori K; Boyle WJ; Hunter T; Karin M
Nature; 1988 Mar; 332(6160):166-71. PubMed ID: 3347253
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4.
Harshman KD; Moye-Rowley WS; Parker CS
Cell; 1988 Apr; 53(2):321-30. PubMed ID: 2834068
[TBL] [Abstract][Full Text] [Related]
6. Identification of three sequence-specific DNA-binding proteins which interact with the Rous sarcoma virus enhancer and upstream promoter elements.
Goodwin GH
J Virol; 1988 Jun; 62(6):2186-90. PubMed ID: 2835519
[TBL] [Abstract][Full Text] [Related]
7. The oncogenicity of jun.
Vogt PK; Bos TJ; Mitsunobu F; Nishimura T; Monteclaro FS; Su HY
Princess Takamatsu Symp; 1989; 20():127-34. PubMed ID: 2562177
[TBL] [Abstract][Full Text] [Related]
8. Avian sarcoma virus 17 carries the jun oncogene.
Maki Y; Bos TJ; Davis C; Starbuck M; Vogt PK
Proc Natl Acad Sci U S A; 1987 May; 84(9):2848-52. PubMed ID: 3033666
[TBL] [Abstract][Full Text] [Related]
9. Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family.
Kataoka K; Nishizawa M; Kawai S
J Virol; 1993 Apr; 67(4):2133-41. PubMed ID: 8383235
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.
Mitchell PJ; Wang C; Tjian R
Cell; 1987 Sep; 50(6):847-61. PubMed ID: 3040262
[TBL] [Abstract][Full Text] [Related]
11. Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes.
Amemiya K; Traub R; Durham L; Major EO
J Biol Chem; 1992 Jul; 267(20):14204-11. PubMed ID: 1321139
[TBL] [Abstract][Full Text] [Related]
12. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
13. Enhancer activity correlates with the oncogenic potential of avian retroviruses.
Weber F; Schaffner W
EMBO J; 1985 Apr; 4(4):949-56. PubMed ID: 2990916
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor I interferes with transformation induced by nuclear oncogenes.
Schuur ER; Kruse U; Iacovoni JS; Vogt PK
Cell Growth Differ; 1995 Mar; 6(3):219-27. PubMed ID: 7794790
[TBL] [Abstract][Full Text] [Related]
15. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
Cleavinger PJ; Shin BA; Kandala JC; Nambiar A; Swamynathan SK; Guntaka RV
Virology; 1996 Aug; 222(1):133-43. PubMed ID: 8806494
[TBL] [Abstract][Full Text] [Related]
16. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family.
van Dam H; Offringa R; Meijer I; Stein B; Smits AM; Herrlich P; Bos JL; van der Eb AJ
Mol Cell Biol; 1990 Nov; 10(11):5857-64. PubMed ID: 2172787
[TBL] [Abstract][Full Text] [Related]
18. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
Kilbey A; Black EJ; Unlu M; Gillespie DA
Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
[TBL] [Abstract][Full Text] [Related]
19. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements.
Lee W; Mitchell P; Tjian R
Cell; 1987 Jun; 49(6):741-52. PubMed ID: 3034433
[TBL] [Abstract][Full Text] [Related]
20. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
Boulden A; Sealy L
Virology; 1990 Jan; 174(1):204-16. PubMed ID: 2152992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]